Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach

Background Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are the most common autoimmune diseases of the central nervous system (CNS). They present chronic relapsing courses that demand treatment with disease-modifying drugs (DMDs) to prevent inflammatory activity. Disea...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Beatriz Ayroza Galvão Ribeiro Gomes, Lucas Bueno Feo, Guilherme Diogo Silva, Caio César Diniz Disserol, Renata Barbosa Paolilo, Amanda Nazareth Lara, Adriana Coracini Tonácio, Maria Fernanda Mendes, Samira Luísa Apóstolos Pereira, Dagoberto Callegaro
Format: Article
Language:English
Published: Thieme Revinter Publicações 2022-10-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1754348
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850169916286566400
author Ana Beatriz Ayroza Galvão Ribeiro Gomes
Lucas Bueno Feo
Guilherme Diogo Silva
Caio César Diniz Disserol
Renata Barbosa Paolilo
Amanda Nazareth Lara
Adriana Coracini Tonácio
Maria Fernanda Mendes
Samira Luísa Apóstolos Pereira
Dagoberto Callegaro
author_facet Ana Beatriz Ayroza Galvão Ribeiro Gomes
Lucas Bueno Feo
Guilherme Diogo Silva
Caio César Diniz Disserol
Renata Barbosa Paolilo
Amanda Nazareth Lara
Adriana Coracini Tonácio
Maria Fernanda Mendes
Samira Luísa Apóstolos Pereira
Dagoberto Callegaro
author_sort Ana Beatriz Ayroza Galvão Ribeiro Gomes
collection DOAJ
description Background Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are the most common autoimmune diseases of the central nervous system (CNS). They present chronic relapsing courses that demand treatment with disease-modifying drugs (DMDs) to prevent inflammatory activity. Disease-modifying drugs lead to immunomodulation or immunosuppression through diverse mechanisms (e.g., shifting lymphocyte and cytokine profile, suppressing specific lymphocyte subpopulations). Thus, patients are more prone to infectious complications and associated worsening of disease. Objective To present feasible strategies for mitigating the infection risk of MS and NMOSD treated patients. Methods Targeted literature review concerning the management of infection risk with an emphasis on vaccination, therapy-specific measures, and particularities of the Brazilian endemic infectious diseases' scenario. Conclusion We propose a vaccination schedule, infectious screening routine, and prophylactic measures based on the current scientific evidence. Awareness of emergent tropical diseases is necessary due to evidence of demyelinating events and possible parainfectious cases of MS and NMOSD.
format Article
id doaj-art-ad4bdf9218024107bf955039befabef5
institution OA Journals
issn 0004-282X
1678-4227
language English
publishDate 2022-10-01
publisher Thieme Revinter Publicações
record_format Article
series Arquivos de Neuro-Psiquiatria
spelling doaj-art-ad4bdf9218024107bf955039befabef52025-08-20T02:20:37ZengThieme Revinter PublicaçõesArquivos de Neuro-Psiquiatria0004-282X1678-42272022-10-0180101057106610.1055/s-0042-1754348Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approachAna Beatriz Ayroza Galvão Ribeiro Gomes0Lucas Bueno Feo1Guilherme Diogo Silva2Caio César Diniz Disserol3Renata Barbosa Paolilo4Amanda Nazareth Lara5Adriana Coracini Tonácio6Maria Fernanda Mendes7Samira Luísa Apóstolos Pereira8Dagoberto Callegaro9Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Divisão de Neurologia,, São Paulo SP, BrazilUniversidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Divisão de Neurologia,, São Paulo SP, BrazilUniversidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Divisão de Neurologia,, São Paulo SP, BrazilUniversidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Divisão de Neurologia,, São Paulo SP, BrazilUniversidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Divisão de Neurologia,, São Paulo SP, BrazilUniversidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Divisão de Doenças Infecciosas e Parasitárias, São Paulo SP, BrazilUniversidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Divisão de Doenças Infecciosas e Parasitárias, São Paulo SP, BrazilUniversidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Divisão de Neurologia,, São Paulo SP, BrazilUniversidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Divisão de Neurologia,, São Paulo SP, BrazilUniversidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Divisão de Neurologia,, São Paulo SP, BrazilBackground Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are the most common autoimmune diseases of the central nervous system (CNS). They present chronic relapsing courses that demand treatment with disease-modifying drugs (DMDs) to prevent inflammatory activity. Disease-modifying drugs lead to immunomodulation or immunosuppression through diverse mechanisms (e.g., shifting lymphocyte and cytokine profile, suppressing specific lymphocyte subpopulations). Thus, patients are more prone to infectious complications and associated worsening of disease. Objective To present feasible strategies for mitigating the infection risk of MS and NMOSD treated patients. Methods Targeted literature review concerning the management of infection risk with an emphasis on vaccination, therapy-specific measures, and particularities of the Brazilian endemic infectious diseases' scenario. Conclusion We propose a vaccination schedule, infectious screening routine, and prophylactic measures based on the current scientific evidence. Awareness of emergent tropical diseases is necessary due to evidence of demyelinating events and possible parainfectious cases of MS and NMOSD.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1754348multiple sclerosisneuromyelitis opticavaccines
spellingShingle Ana Beatriz Ayroza Galvão Ribeiro Gomes
Lucas Bueno Feo
Guilherme Diogo Silva
Caio César Diniz Disserol
Renata Barbosa Paolilo
Amanda Nazareth Lara
Adriana Coracini Tonácio
Maria Fernanda Mendes
Samira Luísa Apóstolos Pereira
Dagoberto Callegaro
Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach
Arquivos de Neuro-Psiquiatria
multiple sclerosis
neuromyelitis optica
vaccines
title Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach
title_full Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach
title_fullStr Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach
title_full_unstemmed Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach
title_short Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach
title_sort reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders a brazilian reference center s approach
topic multiple sclerosis
neuromyelitis optica
vaccines
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1754348
work_keys_str_mv AT anabeatrizayrozagalvaoribeirogomes reducinginfectionriskinmultiplesclerosisandneuromyelitisopticaspectrumdisordersabrazilianreferencecentersapproach
AT lucasbuenofeo reducinginfectionriskinmultiplesclerosisandneuromyelitisopticaspectrumdisordersabrazilianreferencecentersapproach
AT guilhermediogosilva reducinginfectionriskinmultiplesclerosisandneuromyelitisopticaspectrumdisordersabrazilianreferencecentersapproach
AT caiocesardinizdisserol reducinginfectionriskinmultiplesclerosisandneuromyelitisopticaspectrumdisordersabrazilianreferencecentersapproach
AT renatabarbosapaolilo reducinginfectionriskinmultiplesclerosisandneuromyelitisopticaspectrumdisordersabrazilianreferencecentersapproach
AT amandanazarethlara reducinginfectionriskinmultiplesclerosisandneuromyelitisopticaspectrumdisordersabrazilianreferencecentersapproach
AT adrianacoracinitonacio reducinginfectionriskinmultiplesclerosisandneuromyelitisopticaspectrumdisordersabrazilianreferencecentersapproach
AT mariafernandamendes reducinginfectionriskinmultiplesclerosisandneuromyelitisopticaspectrumdisordersabrazilianreferencecentersapproach
AT samiraluisaapostolospereira reducinginfectionriskinmultiplesclerosisandneuromyelitisopticaspectrumdisordersabrazilianreferencecentersapproach
AT dagobertocallegaro reducinginfectionriskinmultiplesclerosisandneuromyelitisopticaspectrumdisordersabrazilianreferencecentersapproach